共 50 条
- [23] Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects The European Journal of Health Economics, 2008, 9 : 7 - 15
- [24] Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 9 (01): : 7 - 15
- [26] OBJECTIVE ASSESSMENT OF INFLUENZA VACCINE EFFICACY IN AN HIGH-RISK HEMODIALYSIS POPULATION CLINICAL RESEARCH, 1978, 26 (03): : A331 - A331
- [27] EFFICACY OF PNEUMOCOCCAL VACCINE IN HIGH-RISK PATIENTS - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (21): : 1318 - 1327
- [30] Using the pneumococcal conjugate vaccine in the pediatric population: Clinical and economic issues AMERICAN JOURNAL OF MANAGED CARE, 2000, 6 (10): : S523 - S525